|
OncoMed Pharmaceuticals, Inc. |
Timothy Hoey |
Disease Team Therapy Planning I |
[REDACTED]: A New Cancer Therapeutic to Reduce CSC Frequency |
$65,120 |
|
University of California, Los Angeles |
Yi Sun |
Basic Biology III |
Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo |
$1,382,400 |
|
University of California, San Francisco |
Holger Willenbring |
Early Translational III |
Generation of safe and therapeutically effective human induced hepatocyte-like cells |
$1,544,170 |
|
Cedars-Sinai Medical Center |
Robert Baloh |
New Faculty Physician Scientist |
Human iPSC modeling and therapeutics for degenerative peripheral nerve disease |
$3,031,737 |
|
University of California, Davis |
Nancy Lane |
Disease Team Therapy Planning I |
Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis |
$110,000 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Basic Biology III |
Mechanisms of Direct Cardiac Reprogramming |
$1,708,560 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Early Translational III |
Direct Cardiac Reprogramming for Heart Regeneration |
$6,319,110 |
|
Beckman Research Institute of City of Hope |
Jiing-Kuan Yee |
Basic Biology III |
Use of human iPS cells to study spinal muscular atrophy |
$1,268,868 |
|
Cedars-Sinai Medical Center |
Dan Gazit |
Disease Team Therapy Planning I |
Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures. |
$109,743 |
|
Stanford University |
Helen Blau |
Early Translational III |
Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients |
$1,825,920 |
|
Stanford University |
Sean Wu |
Basic Biology III |
Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells |
$1,425,600 |
|
University of California, Berkeley |
Song Li |
Basic Biology III |
Induced Pluripotent Stem Cells for Tissue Regeneration |
$1,341,064 |
|
Geron Corporation |
Jane Lebkowski |
Targeted Clinical Development |
Evaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury |
$24,846,856 |
|
Cedars-Sinai Medical Center |
Clive Svendsen |
Disease Team Therapy Planning I |
Stem Cells Secreting GDNF for the Treatment of ALS |
$89,834 |
|
University of California, San Diego |
Mark Tuszynski |
Early Translational III |
Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury |
$4,699,569 |
|
University of California, San Diego |
Deborah Spector |
Basic Biology III |
Viral-host interactions affecting neural differentiation of human progenitors |
$1,372,660 |
|
University of California, Los Angeles |
Ali Nsair |
Basic Biology III |
Characterization and Engineering of the Cardiac Stem Cell Niche |
$1,181,306 |
|
Stanford University |
Robert Robbins |
Disease Team Therapy Planning I |
Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure |
$108,895 |
|
California Polytechnic State University, San Luis Obispo |
Trevor Cardinal |
Bridges |
Masters of Science Specialization in Stem Cell Technology |
$3,020,182 |
|
Stanford University |
Renee Reijo Pera |
Early Translational III |
Autologous iPSC Therapy for Urinary Incontinence |
$5,279,607 |
|
The Parkinson's Institute |
R. Jeremy Nichols |
Basic Biology III |
Understanding the role of LRRK2 in iPSC cell models of Parkinson's Disease |
$1,482,822 |
|
University of California, San Diego |
Anirvan Ghosh |
Basic Biology III |
Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells |
$1,391,400 |
|
University of California, Davis |
Vicki Wheelock |
Disease Team Therapy Planning I |
MSC engineered to produce BDNF for the treatment of Huntington's disease |
$99,248 |
|
California State Polytechnic University, Pomona |
Jill Adler-Moore |
Bridges |
Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education |
$3,008,975 |
|
University of California, San Diego |
Yang Xu |
Early Translational III |
Human ES cell based therapy of heart failure without allogenic immune rejection |
$1,857,600 |
|
Stanford University |
Renee Reijo Pera |
Basic Biology III |
Correlated time-lapse imaging and single cell molecular analysis of human embryo development |
$1,425,600 |
|
Scripps Research Institute |
Joel Gottesfeld |
Basic Biology III |
Triplet Repeat Instability in Human iPSCs |
$1,755,861 |
|
StemCells, Inc. |
Alexandra Capela |
Disease Team Therapy Planning I |
Neuroprotection to treat Alzheimer's: a new paradigm using human central nervous system cells |
$98,050 |
|
California State University, Channel Islands |
Ching-Hua Wang |
Bridges |
Curriculum Development and Implementation of Stem Cell Technology and Laboratory Management Emphasis in an Established MS Biotechnology and Bioinformatics Program at (REDACTED) and Co-development of a GE Course on Stem Cel |
$3,614,553 |
|
University of California, San Diego |
Eugene Yeo |
Early Translational III |
Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons |
$1,654,830 |
|
Stanford University |
Michael Clarke |
Basic Biology III |
USP16 controls stem cell number: implications for Down Syndrome |
$1,425,600 |
|
University of California, Los Angeles |
William Lowry |
Basic Biology III |
Molecular determinants of accurate differentiation from human pluripotent stem cells |
$1,354,230 |
|
University of California, Los Angeles |
Stanley Nelson |
Disease Team Therapy Planning I |
Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy |
$86,414 |
|
California State University, Fullerton |
Nilay Patel |
Bridges |
Stem Cell Training Program - A Bridge to Stem Cell Research |
$2,710,703 |
|
University of California, San Francisco |
Arnold Kriegstein |
Early Translational III |
Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury |
$1,623,251 |
|
Stanford University |
Joanna Wysocka |
Basic Biology III |
Enhancer-mediated gene regulation during early human embryonic development |
$1,425,600 |
|
University of California, Los Angeles |
Shuo Lin |
Basic Biology III |
Etsrp/ER71 mediated stem cell differentiation into vascular lineage |
$1,382,400 |
|
Sanford-Burnham Medical Research Institute |
Marcel Daadi |
Disease Team Therapy Planning I |
Neural Stem Cell-Based Therapy For Parkinson’s Disease |
$99,976 |
|
California State University, Long Beach |
Lisa Klig |
Bridges |
CIRM Stem Cell Research Biotechnology Training Program |
$3,042,698 |
|
University of California, San Diego |
Lawrence Goldstein |
Early Translational III |
Identifying Drugs for Alzheimer's Disease with Human Neurons Made From Human IPS cells |
$1,857,600 |
|
University of California, Los Angeles |
Kathrin Plath |
Basic Biology III |
Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells |
$1,364,598 |
|
Children's Hospital of Los Angeles |
Tracy Grikscheit |
New Faculty Physician Scientist |
The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation |
$3,408,000 |
|
Scripps Research Institute |
Kristin Baldwin |
Basic Biology III |
Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing |
$1,755,864 |
|
California State University, Northridge |
Cindy Malone |
Bridges |
Bridges to Stem Cell Research |
$3,382,877 |
|
The Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Early Translational III |
Direct reprogramming towards vascular progenitors for the treatment of ischemia |
$2,340,000 |
|
University of California, San Francisco |
Harold Bernstein |
Basic Biology III |
Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells |
$1,381,296 |
|
University of California, San Francisco |
Ophir Klein |
New Faculty Physician Scientist |
Stem cell therapy for inflammatory bowel disease |
$3,084,000 |
|
University of California, San Francisco |
John Murnane |
Basic Biology III |
Genomic instability during culturing of human embryonic stem cells |
$1,074,355 |
|
California State University, Sacramento |
Jane Bruner |
Bridges |
Strengthening the Pipeline of Masters-level Scientific and Laboratory Personnel in Stem Cell Research |
$2,773,463 |
|
The Salk Institute for Biological Studies |
David Schubert |
Early Translational III |
Stem cell based small molecule therapy for Alzheimer's disease |
$1,673,757 |
|
University of California, San Francisco |
Jason Pomerantz |
New Faculty Physician Scientist |
Characterization of Human Skeletal Muscle Stem Cells for Clinical Application |
$3,084,000 |
|
University of California, Berkeley |
Michael Rape |
Basic Biology III |
Ubiquitin-dependent control of hESC self-renewal and expansion |
$1,364,091 |
|
California State University, San Bernardino |
Nicole Bournias-Vardiabasis |
Bridges |
Bridges to Stem Cell Research |
$2,607,705 |
|
Cedars-Sinai Medical Center |
Clive Svendsen |
iPSC Consortia Award |
The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development |
$300,000 |
|
University of California, Davis |
John Laird |
Disease Team Therapy Planning I |
Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia |
$76,861 |
|
University of California, San Francisco |
Ann Zovein |
New Faculty Physician Scientist |
Human endothelial reprogramming for hematopoietic stem cell therapy. |
$3,084,000 |
|
Beckman Research Institute of City of Hope |
Stephen Forman |
Early Translational III |
Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells |
$5,217,004 |
|
California State University, San Marcos |
Bianca Mothe |
Bridges |
CIRM Bridges to the Stem Cell Research Training Grant |
$3,613,311 |
|
University of California, Santa Barbara |
Carol Pasternack |
Creativity Awards |
Research Mentorship Program-Immersing High School Students in College Research |
$223,080 |
|
University of California, Davis |
Mehrdad Abedi |
Disease Team Therapy Planning I |
RUNNING TITLE: Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients |
$74,195 |
|
University of California, Los Angeles |
Reza Ardehali |
New Faculty Physician Scientist |
Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors |
$2,930,388 |
|
Stanford University |
Joseph Wu |
Early Translational III |
Heart Repair with Human Tissue Engineered Myocardium |
$4,766,231 |
|
City College Of San Francisco |
Carin Zimmerman |
Bridges |
Stem Cell Training Enhancement Program |
$2,454,307 |
|
Stanford University |
Paul Utz |
Creativity Awards |
[REDACTED] Program: Stem Cell & Developmental Biology Research Internships |
$288,750 |
|
Stanford University |
Judith Shizuru |
Disease Team Therapy Planning I |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$109,676 |
|
University of California, Irvine |
Thomas Lane |
Early Translational III |
Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells |
$4,799,814 |
|
Humboldt State University |
Jacob Varkey |
Bridges |
CIRM Bridges to Stem Cell Research Certificate Program |
$3,497,510 |
|
Children's Hospital of Oakland Research Institute |
Vasanthy Narayanaswami |
Creativity Awards |
[REDACTED] Summer Stem Cell Research Internship Program for High School Students |
$115,500 |
|
University of California, Davis |
Martin Birchall |
Disease Team Therapy Planning I |
Airways for Children |
$71,248 |
|
University of California, Davis |
Walter Boyd |
Early Translational III |
Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair |
$4,939,140 |
|
Pasadena City College |
Pamela Eversole-Cire |
Bridges |
Bridges to Stem Cell Research |
$3,609,138 |
|
University of California, Los Angeles |
Antoni Ribas |
Disease Team Therapy Planning I |
Genetic Re-programming of Stem Cells to Fight Cancer |
$110,000 |
|
University of California, Davis |
Emanual Maverakis |
New Faculty Physician Scientist |
Tunable hydrogels for therapeutic delivery of multipotent stem cells. |
$2,964,000 |
|
University of Southern California |
Toshio Miki |
Early Translational III |
Generation of hepatic cell from placental stem cell for congenital metabolic disorders |
$1,750,375 |
|
San Diego State University |
Ralph Feuer |
Bridges |
CIRM Stem Cell Internship Program |
$3,597,177 |
|
University of California, Davis |
Gerhard Bauer |
Creativity Awards |
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$264,000 |
|
Stanford University |
Albert Wong |
Disease Team Therapy Planning I |
Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma |
$109,750 |
|
University of California, San Diego |
Charles King |
Basic Biology III |
Biological relevance of microRNAs in hESC differentiation to endocrine pancreas |
$1,313,649 |
|
University of California, Los Angeles |
Ali Nsair |
New Faculty Physician Scientist |
Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. |
$3,004,315 |
|
Children's Hospital of Orange County |
Philip Schwartz |
Early Translational III |
Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease |
$5,509,978 |
|
San Francisco State University |
Carmen Domingo |
Bridges |
Bridges to Stem Cell Research |
$3,594,705 |
|
The J. David Gladstone Institutes |
Shannon Noonan |
Creativity Awards |
[REDACTED] Summer Scholars internship program |
$30,690 |
|
Sanford-Burnham Medical Research Institute |
Stuart Lipton |
Disease Team Therapy Planning I |
hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease |
$96,448 |
|
University of California, San Diego |
Kun Zhang |
Basic Biology III |
Functional characterization of mutational load in nuclear reprogramming and differentiation |
$1,382,140 |
|
Stanford University |
Alan Cheng |
New Faculty Physician Scientist |
Enhancing hair cell regeneration in mouse and human inner ear |
$3,091,595 |
|
University of California, Davis |
Kyriacos Athanasiou |
Early Translational III |
Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells |
$1,735,703 |
|
San Jose State University |
Tzvia Abramson |
Bridges |
Stem Cell Internships for Laboratory-based Learning (SCILL) |
$3,614,907 |
|
University of Southern California |
Roberta Brinton |
Creativity Awards |
CIRM STAR High School Summer Research and Creativity Program |
$264,000 |
|
Geron Corporation |
Jane Lebkowski |
Disease Team Therapy Planning I |
Preclinical Development and First-In-Human Testing of [REDACTED] in Advanced Heart Failure |
$106,239 |
|
University of California, San Diego |
Farah Sheikh |
Basic Biology III |
Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC |
$1,341,955 |
|
Scripps Research Institute |
Peter Schultz |
Early Translational III |
Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis |
$4,327,175 |
|
University of California, San Diego |
David Cheresh |
Basic Biology III |
Molecular basis of human ES cell neurovascular differentiation and co-patterning |
$1,361,448 |
|
University of Southern California |
Mohammad Pashmforoush |
New Faculty I |
Transcriptional Regulation of Cardiac Pacemaker Cell Progenitors |
$3,149,806 |
|
University of California, Irvine |
Andrew Putnam |
New Faculty I |
A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells |
$2,108,683 |
|
The Salk Institute for Biological Studies |
Inder Verma |
Early Translational I |
Curing Hematological Diseases |
$6,649,347 |
|
Sanford-Burnham Medical Research Institute |
Evan Snyder |
Early Translational I |
Developmental Candidates for Cell-Based Therapies for Parkinson's Disease (PD) |
$5,416,003 |
|
University of California, Los Angeles |
Gay Crooks |
Basic Biology III |
Forming the Hematopoietic Niche from Human Pluripotent Stem Cells |
$1,375,983 |
|
University of California, Davis |
Alice Tarantal |
Early Translational I |
In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies |
$4,214,592 |
|
Stanford University |
Howard Chang |
New Faculty I |
Noncoding RNAs in Cell Fate Determination |
$3,203,926 |
|
University of California, San Diego |
Eugene Yeo |
Basic Biology III |
Neural and general splicing factors control self-renewal, neural survival and differentiation |
$1,372,660 |